pSivida has received its first quarterly payment of $500,000 from Pfizer as specified by the terms of an exclusive worldwide collaborative research and license agreement signed by the two companies in April, pSivida announced in a press release.
53842
PSivida receives first quarterly payment from Pfizer
169398
Pfizer announces commencement of tender offer for all outstanding shares of Encysive Pharmaceuticals Inc.
51593
Payvia wins contracts from Bright, OnCam, Skype
95584
Wockhardt gains on launching generic of Wellbutrin SR in US
127668
Javelin Pharmaceuticals, Inc. comments on tender offer extension by Hospira
51501
ZymoGenetics offering $79 million in common stock
91515
Pfizer gets the approval
172167
Roche discloses the results of first phase III clinical study using taspoglutide
115268
The Kalixa card has a new payment partner
91902
Pfizer buys rival drugmaker Wyeth for $68 billion
117818
Drug treatment services given £29m funding
164013
First Data to release First quarter
121370
Substance Abuse and mental health Services Administration (SAMHSA) awarding up to $25.9 million
25233
Deal reported to be in tens of millions of dollars
66069
Targacept publicly offering 2.2 million shares
136747
Pfizer to buy Wyeth for $68 billion;
49393
> Credicorp acquires 49.9% stake ...